SCHEMBL16693172

SCHEMBL16693172

N[n+]1ccc(CO)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9481458 0.72 — —
SCHEMBL21490432 0.72 CHKA (0.56) —
SCHEMBL904427 0.72 — —
SCHEMBL10044408 0.72 — —
SCHEMBL22228647 0.72 RAPGEF4 (0.39) —
SCHEMBL41775 0.71 TSHR (0.67) —
Hydrochloric Acid SCHEMBL10766835 0.69 TSHR (0.42) —
SCHEMBL294241 0.69 CHKA (0.52) —
SCHEMBL31672218 0.65 TSHR (0.59) —
SCHEMBL92935 0.65 LPL (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727940-A1 DIHYDROPYRIMIDINE-2, 4 (1H, 3H) -DIONE-CONTAINING POLYCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREOF AND USE THEREOF Linkcure Therapeutics (KY) 2026-04-22 — — EP disclosed
WO-2024255810-A1 DIHYDROPYRIMIDINE-2, 4 (1H, 3H) -DIONE-CONTAINING POLYCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREOF AND USE THEREOF HANGZHOU GLUBIO PHARMACEUTICAL CO., LTD (CN) 2024-12-19 — — WO disclosed
WO-2020153676-A1 A FUSED RING HETEROARYL COMPOUND AS AN ALK4/5 INHIBITOR BISICHEM CO., LTD. (KR) 2020-07-30 — — WO disclosed
WO-2015066371-A1 SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2015-05-07 — — WO disclosed
Send feedback